MBX Biosciences CEO receives options and RSUs
MBX Biosciences, Inc. reported equity awards to President and CEO Steven L. Hoerter on August 3, 2026.
Rhea-AI Filing Summary
MBX Biosciences, Inc. reported equity awards to President and CEO Steven L. Hoerter on August 3, 2026. He received stock options for 331000.0000 shares of common stock at a $64.4100 exercise price, vesting 25% on July 13, 2027 and in 36 equal monthly installments thereafter, expiring August 3, 2036. He also received 71000.0000 restricted stock units vesting 25% annually each July 13 from 2027 through 2030. Following these grants he directly held 82938.0000 common shares, while 20000.0000 additional shares are held by the Steven L Hoerter Revocable Trust, with beneficial ownership disclaimed except for any pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 402,000 shares
Grant/Award
3 txns
Insider
Hoerter Steven L.
Role
President and CEO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock option (right to buy) F3 | 331,000 | $0.00 | $0.00 |
| Grant/Award | Common Stock F1 | 71,000 | $0.00 | $0.00 |
| holding | Common Stock F2 | -- | -- | -- |
Holdings After Transaction:
Stock option (right to buy) — 331,000 contracts (Direct);
Common Stock — 82,938 shares (Direct);
Common Stock — 20,000 shares (Indirect, Trust)
Footnotes (3)
- F1. Represents the grant of restricted stock units ("RSUs"). 25% of the shares subject to the RSU grant will vest annually over four years, on each July 13, 2027, 2028, 2029 and 2030, subject to continued service on each such vesting date.
- F2. Shares held by the Steven L Hoerter Revocable Trust dated November 2, 2018, of which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose.
- F3. The options will vest and become exercisable with 25% of the shares subject to the award vesting on July 13, 2027 and the remainder vesting in 36 equal monthly installments thereafter, subject to continued service on each such vesting date.
Key Figures
Stock options granted: 331000.0000 shares
Option exercise price: $64.4100 per share
Option expiration date: 2036-08-03
+3 more
6 metrics
Stock options granted
331000.0000 shares
Stock option award to CEO on 2026-08-03
Option exercise price
$64.4100 per share
Exercise price for 331000.0000 stock options
Option expiration date
2036-08-03
Expiration of CEO stock option grant
RSUs granted
71000.0000 shares
Restricted stock units granted to CEO on 2026-08-03
Direct common stock holdings
82938.0000 shares
CEO direct common stock position following reported grants
Trust-held common shares
20000.0000 shares
Shares held by the Steven L Hoerter Revocable Trust with beneficial ownership disclaimed
Key Terms
restricted stock units ("RSUs"), Revocable Trust, pecuniary interest
3 terms
restricted stock units ("RSUs") financial
"Represents the grant of restricted stock units ("RSUs"). 25% of the"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
Revocable Trust financial
"Shares held by the Steven L Hoerter Revocable Trust dated"
A revocable trust is a legal arrangement where the person who creates it keeps control and can change or cancel the trust at any time, while naming who will manage and receive the assets later. Think of it like a flexible folder for your investments and property that can be relabeled or reworked as circumstances change; it matters to investors because it determines how ownership is recorded, how easily assets transfer on incapacity or death, and whether holdings bypass public probate proceedings.
pecuniary interest financial
"disclaims beneficial ownership except to the extent of any pecuniary interest"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did MBX (MBX) grant to CEO Steven L. Hoerter?
Steven L. Hoerter received 331000.0000 stock options at a $64.4100 exercise price and 71000.0000 RSUs. The options and RSUs are compensation awards that vest over several years, tying a significant portion of his pay to MBX equity performance.
What is the vesting schedule for the new MBX (MBX) stock options?
The options vest with 25% of the shares on July 13, 2027, then in 36 equal monthly installments. This creates a roughly four-year vesting period, requiring continued service through each vesting date before the options become fully exercisable.
How do the MBX (MBX) restricted stock units granted to the CEO vest?
The 71000.0000 RSUs vest 25% on each July 13 in 2027, 2028, 2029 and 2030. Each annual vesting tranche requires Mr. Hoerter to remain in service on the applicable date before those shares of common stock are delivered.
What are the key terms of the MBX (MBX) stock options granted to the CEO?
The options cover 331000.0000 shares at a $64.4100 exercise price and expire August 3, 2036. They vest over time beginning July 13, 2027, aligning Mr. Hoerter’s potential gains with longer-term MBX share performance.
AI-generated analysis. How Rhea-AI works. Not financial advice.
